- Home
- ACHV vs LPSN Comparison
ACHV vs LPSN Comparison
Compare ACHV & LPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- LPSN
- Stock Information
- Founded
- ACHV N/A
- LPSN 1995
- Country
- ACHV United States
- LPSN United States
- Employees
- ACHV N/A
- LPSN N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- LPSN EDP Services
- Sector
- ACHV Health Care
- LPSN Technology
- Exchange
- ACHV Nasdaq
- LPSN Nasdaq
- Market Cap
- ACHV 72.5M
- LPSN 72.8M
- IPO Year
- ACHV N/A
- LPSN 2000
- Fundamental
- Price
- ACHV $2.26
- LPSN $1.07
- Analyst Decision
- ACHV Strong Buy
- LPSN Hold
- Analyst Count
- ACHV 3
- LPSN 3
- Target Price
- ACHV $14.33
- LPSN $1.20
- AVG Volume (30 Days)
- ACHV 1.2M
- LPSN 1.3M
- Earning Date
- ACHV 08-12-2025
- LPSN 07-30-2025
- Dividend Yield
- ACHV N/A
- LPSN N/A
- EPS Growth
- ACHV N/A
- LPSN N/A
- EPS
- ACHV N/A
- LPSN N/A
- Revenue
- ACHV N/A
- LPSN $292,025,000.00
- Revenue This Year
- ACHV N/A
- LPSN N/A
- Revenue Next Year
- ACHV N/A
- LPSN $0.82
- P/E Ratio
- ACHV N/A
- LPSN N/A
- Revenue Growth
- ACHV N/A
- LPSN N/A
- 52 Week Low
- ACHV $1.84
- LPSN $0.57
- 52 Week High
- ACHV $5.31
- LPSN $2.08
- Technical
- Relative Strength Index (RSI)
- ACHV 35.12
- LPSN 71.39
- Support Level
- ACHV $2.00
- LPSN $0.88
- Resistance Level
- ACHV $3.90
- LPSN $1.04
- Average True Range (ATR)
- ACHV 0.28
- LPSN 0.08
- MACD
- ACHV -0.18
- LPSN 0.03
- Stochastic Oscillator
- ACHV 13.68
- LPSN 84.78
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.